Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies

Cell Oncol (Dordr). 2023 Sep 18. doi: 10.1007/s13402-023-00874-x. Online ahead of print.

Abstract

Excessive fibrosis is a predominant feature of pancreatic stroma and plays a crucial role in the development and progression of pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP). Emerging evidence showed diversity and heterogeneity of fibroblasts play crucial and somewhat contradictory roles, the interactions between fibroblasts and pancreatic cells or infiltrating immune cells are of great importance during PDAC and CP progression, with some promising therapeutic strategies being tested. Therefore, in this review, we describe the classification of fibroblasts and their functions in PDAC and pancreatitis, the mechanisms by which fibroblasts mediate the development and progression of PDAC and CP through direct or indirect interaction between fibroblast and pancreatic parenchymal cells, or by remodeling the pancreatic immune microenvironment mediates the development and progression of PDAC and CP. Finally, we summarized the current therapeutic strategies and agents that directly target subtypes of fibroblasts or interfere with their essential functions.

Keywords: Cancer-associated fibroblast; Pancreatic fibrosis; Subtypes of fibroblasts; Tumor microenvironment.

Publication types

  • Review